Skip to main content
  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2022 cycle, please contact [email protected].

No Filters Selected
          CBE ID Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          0555 INR Monitoring for Individuals on Warfarin Pharmacy Quality Alliance Endorsed
          0556 INR for Individuals Taking Warfarin and Interacting Anti-Infective Medications Centers for Medicare & Medicaid Services Endorsement Removed
          0557 HBIPS-6 Post discharge continuing care plan created The Joint Commission Endorsement Removed
          0558 HBIPS-7 Post discharge continuing care plan transmitted to next level of care provider upon discharge The Joint Commission Endorsement Removed
          0559 Combination chemotherapy or chemo-immunotherapy (if HER2 positive), is recommended or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0 or stage IB - III hormone receptor negative breast cancer American College of Surgeons Endorsement Removed
          0560 HBIPS-5 Patients discharged on multiple antipsychotic medications with appropriate justification The Joint Commission Endorsement Removed
          0561 Melanoma Coordination of Care Physician Consortium for Performance Improvement Endorsement Removed
          0562 Overutilization of Imaging Studies in Melanoma American Academy of Dermatology Endorsement Removed
          0563 Primary Open-Angle Glaucoma: Reduction of Intraocular Pressure by 15% or Documentation of a Plan of Care American Academy of Ophthalmology Endorsed
          0564 Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures American Academy of Ophthalmology Endorsed
          Displaying 551 - 560 of 1219

          The Submission Tool and Repository (STAR) is a measure database of quality performance measures that have been submitted to the previous consensus-based entity for endorsement review. The STAR database will be updated regularly as new and maintenance measures are submitted to the Partnership for Quality Measurement for endorsement review. Battelle will be providing additional enhancements to the STAR database as measure information is submitted in order to better support the accessibility of timely and accurate measure information for all interested parties.